ELI
ALXN
Empire Life Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-996
| Closed | -$183K | – | 106 |
|
|
2021
Q2 | $183K | Sell |
996
-199,910
| -100% | -$36.7M | 0.01% | 100 |
|
|
2021
Q1 | $30.7M | Sell |
200,906
-93,608
| -32% | -$14.3M | 2.11% | 17 |
|
|
2020
Q4 | $46M | Sell |
294,514
-8,945
| -3% | -$1.4M | 3.25% | 7 |
|
|
2020
Q3 | $34.7M | Buy |
303,459
+937
| +0.3% | +$107K | 2.79% | 12 |
|
|
2020
Q2 | $34M | Sell |
302,522
-2,289
| -0.8% | -$257K | 2.98% | 10 |
|
|
2020
Q1 | $27.4M | Buy |
304,811
+53,607
| +21% | +$4.81M | 2.5% | 13 |
|
|
2019
Q4 | $27.2M | Buy |
251,204
+38,329
| +18% | +$4.15M | 2.07% | 20 |
|
|
2019
Q3 | $20.8M | Buy |
212,875
+115,239
| +118% | +$11.3M | 1.75% | 26 |
|
|
2019
Q2 | $12.8M | Buy |
97,636
+1,364
| +1% | +$179K | 1.03% | 41 |
|
|
2019
Q1 | $13M | Sell |
96,272
-21,553
| -18% | -$2.91M | 1.09% | 41 |
|
|
2018
Q4 | $11.5M | Buy |
+117,825
| New | +$11.5M | 1.03% | 41 |
|